Description
An open-label, single-arm study to evaluate the effectiveness and safety of ocrelizumab in patients with early stage relapsing remitting multiple sclerosis.
Principal Investigator
Funder
Genentech, Inc.
Related Studies
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Mindfulness and Migraine: A Randomized Controlled Trial
Investigator: Sylvia Sudat, PhD